Lung Cancer Clinical Trial
Prospective Clinicogenomic Program
The main purpose of this study is to evaluate the feasibility of a scalable, prospective research program for participants with metastatic non-small cell lung cancer (mNSCLC) or extensive-stage small-cell lung cancer (ES-SCLC) planning to start standard-of-care (SOC) systemic anti-cancer treatment. The study will also examine ctDNA status over the course of treatment as a predictor of response to therapy.
Documented diagnosis of mNSCLC or ES-SCLC
Planned initiation of SOC systemic anti-cancer treatment
Front-Line Immunotherapy Cohort: Received front-line treatment of an immune blockade therapy including anti-CTLA-4, anti-PD-1, or anti-PD-L1 therapeutic antibody on Protocol GX41563
- Participant actively receiving investigational medicinal product(s) as part of an interventional trial at the time of signing informed consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 23 Locations for this study
Birmingham Alabama, 35205, United States
Huntsville Alabama, 35805, United States
Chandler Arizona, 85224, United States
New Haven Connecticut, 06510, United States
Fort Myers Florida, 33901, United States
Saint Petersburg Florida, 33705, United States
Tallahassee Florida, 32308, United States
West Palm Beach Florida, 33401, United States
Athens Georgia, 30607, United States
Atlanta Georgia, 30318, United States
Fort Wayne Indiana, 46845, United States
Grand Rapids Michigan, 49503, United States
Jackson Mississippi, 39202, United States
Lincoln Nebraska, 68510, United States
East Brunswick New Jersey, 08816, United States
East Syracuse New York, 13057, United States
New York New York, 10055, United States
Port Jefferson Station New York, 11776, United States
Tulsa Oklahoma, 74146, United States
Chattanooga Tennessee, 37404, United States
Nashville Tennessee, 37203, United States
Fredericksburg Virginia, 22408, United States
Richmond Virginia, 23236, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.